share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Jan 19 21:06

Gainers

  • Mesoblast (NASDAQ:MESO) shares increased by 22.1% to $2.1 during Friday's pre-market session. The company's market cap stands at $180.2 million.
  • Sangamo Therapeutics (NASDAQ:SGMO) stock rose 20.27% to $0.5. The company's market cap stands at $88.6 million.
  • Telesis Bio (NASDAQ:TBIO) stock increased by 19.27% to $0.37. The market value of their outstanding shares is at $11.1 million.
  • INVO Bioscience (NASDAQ:INVO) stock rose 17.43% to $1.28. The company's market cap stands at $3.1 million.
  • Coherus BioSciences (NASDAQ:CHRS) stock increased by 14.99% to $2.76. The market value of their outstanding shares is at $307.3 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares increased by 14.35% to $2.43. The company's market cap stands at $1.6 million.

Losers

  • Esperion Therapeutics (NASDAQ:ESPR) stock fell 17.7% to $1.77 during Friday's pre-market session. The market value of their outstanding shares is at $201.2 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock declined by 15.47% to $1.1. The market value of their outstanding shares is at $1.3 million.
  • Accelerate Diagnostics (NASDAQ:AXDX) shares fell 10.91% to $1.43. The market value of their outstanding shares is at $20.8 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock declined by 9.47% to $0.12. The company's market cap stands at $29.9 million.
  • Nuwellis (NASDAQ:NUWE) stock decreased by 9.12% to $0.41. The company's market cap stands at $1.3 million.
  • MorphoSys (NASDAQ:MOR) stock declined by 8.7% to $9.35. The market value of their outstanding shares is at $1.4 billion. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment